Apotekaonline
Your Cart

Myfortic 180 mg and 360 mg gastro-resistant tablets – mycophenolic acid after kidney transplantation

Myfortic
Myfortic 180 mg and 360 mg gastro-resistant tablets – mycophenolic acid after kidney transplantation
Slični proizvodi
Proizvod trenutno nemamo na stanju ili je zabranjena prodaja online.

Pogledajte blok ispod gde možete pronaći proizvode koji su slični ili imaju slična dejstva kao proizvod na čijoj se stranici nalazite.
Myfortic is a medicine in the form of gastro-resistant tablets containing mycophenolic acid (as mycophenolate sodium) – an immunosuppressant that redu..
0.00 RSD
  • Stock: Zabrana online prodaje
  • Brand: NOVARTIS
  • Model: BR-605765517

Myfortic is a medicine in the form of gastro-resistant tablets containing mycophenolic acid (as mycophenolate sodium) – an immunosuppressant that reduces the activity of the immune system.

It is used in adults after kidney transplantation, together with ciclosporin and corticosteroids, to prevent rejection of the transplanted organ. It is authorised in strengths of 180 mg and 360 mg. Treatment is prescribed and monitored by a doctor experienced in transplantation.

Important warning

  • Dispensing status: the medicine is used in an inpatient healthcare institution; exceptionally it may be dispensed on prescription to continue treatment at home, which must be stated and certified on the back of the prescription.
  • Mycophenolate causes birth defects and miscarriage. Women who can become pregnant must have a negative pregnancy test before starting treatment and use effective contraception.
  • The medicine increases susceptibility to infections and the risk of skin cancer – limit sun exposure and report signs of infection immediately.
  • Mycophenolic acid is not the same as mycophenolate mofetil – do not switch to another medicine without your doctor's decision.
  • This page is for information only and is not an offer to buy the medicine online.

What is Myfortic used for and how is it taken correctly after kidney transplantation?

Basic information about the medicine

Medicine nameMyfortic®, 180 mg and 360 mg, gastro-resistant tablets
Active substancemycophenolic acid (as mycophenolate sodium)
Strength180 mg and 360 mg
Pharmaceutical formgastro-resistant tablet
Therapeutic groupimmunosuppressants – selective immunosuppressants (ATC L04AA06)
Packcarton of 120 tablets (12 blisters of 10) for each strength
Marketing authorisation holder / manufacturerRepresentative office Novartis Pharma Services Inc. Belgrade (Novi Beograd); manufacturers Novartis Pharma Produktions GmbH (Germany), Novartis Pharmaceutical Manufacturing LLC (Slovenia), Novartis Farmaceutica S.A. (Spain)
Dispensing statusSZR – inpatient healthcare institution; exceptionally on prescription to continue treatment at home

What is Myfortic used for?

According to the patient information leaflet and the summary of product characteristics, Myfortic is indicated:

  • in combination with ciclosporin and corticosteroids for the prevention (prophylaxis) of acute transplant rejection in adult patients who have received a kidney transplant.

How is Myfortic used and dosed?

The medicine may only be prescribed by a doctor experienced in treating transplant patients. According to the leaflet:

  • Recommended daily dose: 1440 mg (8 tablets of 180 mg or 4 tablets of 360 mg), divided into 2 doses of 720 mg each (4 tablets of 180 mg or 2 tablets of 360 mg) – in the morning and in the evening.
  • The first dose of 720 mg is taken within the first 72 hours after transplantation.
  • Swallow the tablets whole with a glass of water; do not break or crush them and do not take a damaged or broken tablet.
  • The medicine can be taken with or without food, but the chosen way should be kept every day so that the same amount of medicine is absorbed.
  • Treatment lasts as long as immunosuppression is needed to prevent rejection of the transplanted organ.

Special patient groups

  • Children and adolescents: use is not recommended because of insufficient data.
  • Elderly patients (65 years and older): no dose adjustment is needed (720 mg twice daily), but they may have more side effects because of a reduced immune response.
  • Severe kidney impairment: patients should be monitored carefully and the daily dose must not exceed 1440 mg.
  • Liver impairment: no dose adjustment is needed in kidney transplant patients with severe liver impairment.

Contraindications – when the medicine must not be used

  • allergy to mycophenolic acid, mycophenolate sodium, mycophenolate mofetil or any of the excipients;
  • women who can become pregnant and have not provided a negative pregnancy test before the medicine is prescribed;
  • pregnancy, planned pregnancy or suspected pregnancy;
  • not using effective contraception;
  • breastfeeding.

Precautions and warnings

  • a severe digestive disorder, now or in the past (e.g. stomach ulcer);
  • rare hereditary deficiency of the enzyme HGPRT (Lesch-Nyhan or Kelley-Seegmiller syndrome);
  • the medicine reduces the skin's protection against sunlight and increases the risk of skin cancer – wear protective clothing and apply a high-protection sunscreen frequently;
  • existing hepatitis B or C – the disease may reactivate; yellowing of the skin and eyes, nausea, loss of appetite or dark urine require contacting a doctor immediately;
  • persistent cough or difficulty breathing, signs of infection (fever, sore throat), unexpected bruising or bleeding – tell your doctor immediately; the doctor monitors the blood count and, if necessary, antibody levels;
  • you must not donate blood during treatment and for at least 6 weeks afterwards; men must not donate sperm during treatment and for at least 90 days afterwards;
  • the medicine contains lactose and sodium (13 mg per 180 mg tablet, 26 mg per 360 mg tablet).

Interactions with other medicines, food and drink

  • other immunosuppressants, e.g. azathioprine or tacrolimus;
  • colestyramine (a cholesterol-lowering medicine);
  • activated charcoal (used for diarrhoea, wind and upset stomach);
  • antacids containing magnesium and aluminium;
  • antiviral medicines, e.g. aciclovir and ganciclovir;
  • vaccinations – tell your doctor if you plan any vaccination;
  • the medicine can be taken with or without food, but the same way every day.

Pregnancy and breastfeeding

  • Pregnancy: the medicine is contraindicated. Mycophenolate causes miscarriages (about 50%) and serious birth defects (23–27%) – e.g. malformations of the ears, eyes, face (cleft lip/palate), fingers, heart, oesophagus, kidneys and nervous system. If you become pregnant during treatment, tell your doctor immediately, but keep taking the medicine until you see the doctor.
  • Contraception in women: effective contraception before starting, throughout treatment and for 6 weeks after the last dose; using 2 methods of contraception is advised.
  • Contraception in men: as a precaution, reliable contraception is advised during treatment and for 90 days after stopping the medicine.
  • Breastfeeding: the medicine must not be taken while breastfeeding, as small amounts pass into breast milk.

Driving and using machines

  • Myfortic has a minor influence on the ability to drive and use machines.

Possible side effects

  • Serious – contact a doctor immediately: signs of infection (fever, chills, sweating, tiredness, drowsiness, lack of energy); vomiting blood, black or bloody stools, stomach or intestinal ulcer; swollen glands, a new or growing skin lump or a change in a mole.
  • Very common: low white blood cell count, low calcium and potassium levels, raised uric acid, high blood pressure, anxiety, diarrhoea, joint pain.
  • Common: anaemia, low platelet count, raised potassium, low magnesium, dizziness, headache, cough, low blood pressure, shortness of breath, abdominal pain and bloating, constipation, nausea, vomiting, tiredness, fever, abnormal liver or kidney function tests, respiratory infections, acne, weakness, muscle pain, swelling of hands and feet, itching.
  • Uncommon: fast or irregular heartbeat, fluid in the lungs, lymphocele, shivering, sleep disorders, conjunctivitis, blurred vision, inflammation of the pancreas, infections of bones, blood and skin, blood in urine, hair loss, raised blood fats and sugar, signs of interstitial lung disease and others.
  • Frequency not known: rash; agranulocytosis (fever, sore throat, frequent infections).

Overdose, missed dose and stopping treatment

  • Overdose: if you have taken more than you should or someone else has taken your tablets, talk to a doctor immediately or go to the nearest hospital and take the tablets or the empty pack with you.
  • Missed dose: take it as soon as you remember, unless it is almost time for the next dose; then continue as usual. Do not take a double dose.
  • Stopping treatment: do not stop without your doctor's advice – stopping may increase the risk of rejection of the transplanted organ.

When to seek medical help immediately?

  • fever, chills, sore throat or other signs of infection;
  • vomiting blood, black or bloody stools;
  • unexpected bruising or bleeding;
  • yellowing of the skin and eyes, dark urine;
  • persistent cough or difficulty breathing;
  • a missed period or suspected pregnancy.

Pharmacist's advice

Decide whether you will take Myfortic with or without a meal and stick to it every day – this way the same amount of medicine is absorbed daily. Do not break the tablets: the gastro-resistant coating protects the medicine, and the powder must not reach the skin, mucous membranes or eyes.

Before buying any non-prescription medicine, antacid or activated charcoal product, check with a pharmacist – antacids with magnesium and aluminium and activated charcoal can affect Myfortic. Apply a high-protection sunscreen every day, even when it is cloudy.

Ljubica Barbulović – Master of Pharmacy

Availability and price

Myfortic is a medicine for use in an inpatient healthcare institution, exceptionally dispensed on a specially certified prescription to continue treatment at home. ApotekaOnline.rs does not sell prescription medicines over the internet; this page is for information only.

For availability and dispensing conditions, contact your transplant centre or a pharmacy with a valid prescription.

Related information

Myfortic is a specialist immunosuppressive treatment after kidney transplantation; further information about the treatment is provided by the transplant centre doctors and your pharmacist.

Composition, pack and manufacturer

  • Active substance: mycophenolic acid (as mycophenolate sodium) – 180 mg or 360 mg per gastro-resistant tablet.
  • Excipients – core: maize starch; povidone (K-30); crospovidone; anhydrous lactose; colloidal anhydrous silica; magnesium stearate. Coating (180 mg): hypromellose phthalate; titanium dioxide (E171); yellow iron(III) oxide (E172); indigotine (E132). Coating (360 mg): hypromellose phthalate; titanium dioxide (E171); yellow and red iron(III) oxide (E172).
  • Appearance: 180 mg – round, light green tablets marked "C"; 360 mg – oblong, pale orange-red tablets marked "CT".
  • Pack: PA/Al/PVC/Al blister with 10 tablets; 12 blisters (120 tablets) per carton.
  • Marketing authorisation holder: Representative office Novartis Pharma Services Inc. Belgrade (Novi Beograd), Omladinskih brigada 90A, Belgrade.
  • Authorisation numbers: 180 mg – 000986469 2024 of 6 December 2024; 360 mg – 000986702 2024 of 6 December 2024.

Storage

  • Store below 30 °C in the original package to protect from moisture.
  • Shelf life: 3 years.
  • Do not use a pack that is damaged or shows signs of tampering.
  • Keep out of the sight and reach of children.

Frequently asked questions

Is Myfortic the same as mycophenolate mofetil (e.g. CellCept)?

No. Both release mycophenolic acid, but they differ in form and dosing (720 mg mycophenolate sodium corresponds to 1 g mycophenolate mofetil). You must not switch between them yourself – your doctor decides.

Why is contraception so important during treatment?

Mycophenolate causes miscarriages and serious birth defects. Women who can become pregnant must therefore have a negative test before starting and use effective contraception (2 methods are advised) during treatment and for 6 weeks afterwards; men are advised to use reliable contraception for another 90 days after treatment ends.

May I break the tablet if I find it hard to swallow?

No – the tablets are swallowed whole. Breaking damages the gastro-resistant coating, and the powder must not reach the skin, mucous membranes or eyes. If you have trouble swallowing, talk to your doctor.

How should I protect myself from the sun while taking Myfortic?

The medicine increases the risk of skin cancer, so the leaflet advises limiting exposure to sunlight and UV light, wearing protective clothing and frequently using high-protection sunscreen. Show any new or changed skin lesion to your doctor.

Sources

Sources checked on: 25 October 2026.

Write a review

Note: HTML is not translated!
Bad Good
Captcha

Pharmacy Online has a contract with the Daily Express courier service and it is delivered on the territory of the Republic of Serbia through this service. Exports of goods to foreign countries are done through DHL and PostExport.

For all orders received up to 12h from Monday to Friday, the approximate delivery time is 2-4 business days for the whole territory of the Republic of Serbia. In case the order is placed on weekends (Saturdays and Sundays), the delivery is done as well as for the orders received on Monday - so next business day.

Deliveries are not made on Saturdays and Sundays.

Additional information

The items will be packed so that they cannot be damaged by normal handling of the goods in transit. When picking up the product, the buyer is obliged to check for any damage and immediately advertise it to the courier who delivered the goods, or refuse to take over the shipment, which shows the external damage. Any subsequent product claims for shipping damage will not be considered.

When picking up the product, the customer is required to sign the delivery note taken by the Daily Express delivery worker. The delivery note is considered to be a receipt and delivery note.

The courier service delivers the goods to the address, ie. does not bring into the living space.


Delivery restrictions on goods

Delivery of items purchased on the site www.apotekaonline.rs is made exclusively through the Daily Express courier service in the territory of the Republic of Serbia. Delivery outside the territory of the Republic of Serbia, ie export of goods, is done exclusively through the service of DHL and PostExport Post of Serbia.


Shipping cost

For the territory of the Republic of Serbia:

For goods ordered up to 5.000,00 RSD, delivery charge is 350.00 RSD (VAT included). For goods over 5.000,00 RSD, shipping is free of charge.

For international delivery:

For the export of goods abroad through the PostExport service of Post of Serbia, the shipping price is for:

  • Zone I (Slovenia, Croatia, Bosnia and Herzegovina, Montenegro, Northern Macedonia) - 1,280.00 RSD
  • Zone II (Other European countries) - 1,790.00 RSD
  • Zone III (Asia, Africa, America, Australia and other countries) - 2,650.00 RSD

Delivery time is 15 days or more (depending on the country of delivery)

For export of goods abroad through DHL service, the shipping price is 2,700.00 RSD. Delivery time is 1-5 business days (depending on the country of delivery)

Shipping cost is with tax. The price includes the delivery of the parcel to the buyer's address with the associated tax and customs at the seller's expense. A possible additional cost may be a customs charge against the buyer, depending on the country to which the package is being shipped.

For any additional questions, complaints or checking the current location of your shipment, please contact us at the following e-mail address: info@apotekaonline.rs